Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

11.11

0.16 (1.46%)

At close: Jun 18, 2025, 12:37 PM

Rapport Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Net Income	-24.06M	-19.98M	-17.54M	-18.12M	-22.67M	-13.52M	-8.71M	-6.41M	-6.15M
Depreciation & Amortization	244K	260K	219K	208K	152K	53K	23K	21K	15K
Stock-Based Compensation	4.04M	3.21M	3.18M	2.35M	1.49M	998K	859K	945K	723K
Other Working Capital	n/a	693K	3.23M	-123K	-3.16M	1.22M	1.65M	-1.15M	-422K
Other Non-Cash Items	n/a	725K	-5.56M	2.1M	8.36M	167K	119K	987K	1.78M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	1.34M	3.28M	-123K	-3.16M	1.94M	2.28M	-1.15M	-422K
Operating Cash Flow	-20.24M	-14.45M	-16.41M	-16.35M	-17.61M	-10.36M	-5.42M	-6.6M	-4.8M
Capital Expenditures	-291K	-226K	-140K	-967K	-1.07M	-1.44M	-52K	-86K	-61K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-43.67M	-84.56M	-113.51M	-138.43M	-44.8M	-77.22M	n/a	n/a	n/a
Sales Maturities Of Investments	64.56M	116.72M	56.84M	32.29M	3.95M	n/a	n/a	n/a	n/a
Other Investing Acitivies	436K	n/a	3.77M	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	21.03M	31.93M	-53.04M	-107.1M	-41.93M	-78.66M	-52K	-86K	-61K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6K	7K	n/a	283K	-283K	-134K	58K	-40K	-18K
Financial Cash Flow	5K	7K	-1.39M	159.35M	63.66M	-140K	85.36M	-90K	60.01M
Net Cash Flow	799K	17.49M	-70.85M	35.9M	4.12M	-89.16M	79.88M	-6.78M	55.14M
Free Cash Flow	-20.53M	-14.67M	-16.55M	-17.32M	-18.69M	-11.79M	-5.48M	-6.68M	-4.86M